lidokain "aguettant" 10 mg/ml injektionsvæske, opløsning i fyldt injektionssprøjte
laboratoire aguettant - lidocainhydrochloridmonohydrat - injektionsvæske, opløsning i fyldt injektionssprøjte - 10 mg/ml
lidokain "aguettant" 20 mg/ml injektionsvæske, opløsning i fyldt injektionssprøjte
laboratoire aguettant - lidocainhydrochloridmonohydrat - injektionsvæske, opløsning i fyldt injektionssprøjte - 20 mg/ml
waylivra
akcea therapeutics ireland limited - volanesorsen natrium - hyperlipoproteinæmi type i - andre lipid ændring af agenter - waylivra er indiceret som et supplement til kosten i voksne patienter med genetisk bekræftet familiær chylomicronemia syndrom (fcs) og høj risiko for pancreatitis, i, som reaktion på kost og sænke triglycerid terapi har været utilstrækkelig.
alendronate/cholecalciferol "accord" 70 mg+70 mikrogram tabletter
accord healthcare b.v. - alendronsyre, cholecalciferoltrituration - tabletter - 70 mg+70 mikrogram
dienogest "besins" 2 mg tabletter
laboratoires besins int. s.a.s. - dienogest - tabletter - 2 mg
nitisinone "dipharma" 2 mg kapsler, hårde
dipharma arzneimittel gmbh - nitisinon - kapsler, hårde - 2 mg
spikevax (previously covid-19 vaccine moderna)
moderna biotech spain, s.l. - single-stranded, 5’-capped messenger rna (mrna) produced using a cell-free in vitro transcription from the corresponding dna templates, encoding the viral spike (s) protein of sars-cov-2 - covid-19 virus infection - vacciner - spikevax is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 6 months of age and older. spikevax bivalent original/omicron ba. 1 is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 6 years of age and older who have previously received at least a primary vaccination course against covid-19. spikevax bivalent original/omicron ba. 4-5 is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 6 months of age and older. spikevax xbb. 5 is indicated for active immunisation to prevent covid 19 caused by sars-cov-2 in individuals 6 months of age and older. the use of this vaccine should be in accordance with official recommendations.
vydura
pfizer europe ma eeig - rimegepant - migræneforstyrrelser - antimigraine preparations, calcitonin gene-related peptide (cgrp) antagonists - vydura is indicated for theacute treatment of migraine with or without aura in adults;preventative treatment of episodic migraine in adults who have at least 4 migraine attacks per month.
eladynos
theramex ireland limited - abaloparatide - osteoporosis, postmenopausal; osteoporosis - calciumhomeostase - behandling af osteoporose hos postmenopausale kvinder med øget risiko for brud.
bonjesta 20+20 mg tabletter med modificeret udløsning
exeltis healthcare s.l - doxylaminhydrogensuccinat, pyridoxinhydrochlorid - tabletter med modificeret udløsning - 20+20 mg